These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 34199359

  • 21. Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics.
    Kim JY, Park SY, Park SH, Lee G, Jin JS, Kim D, Park JH, Jeong SY, Ko YJ.
    Vaccines (Basel); 2024 Feb 12; 12(2):. PubMed ID: 38400168
    [Abstract] [Full Text] [Related]

  • 22. Selection of Vaccine Candidate for Foot-and-Mouth Disease Virus Serotype O Using a Blocking Enzyme-Linked Immunosorbent Assay.
    Cao Y, Li K, Xing X, Bao H, Huang N, Zhu G, Bai X, Sun P, Fu Y, Li P, Zhang J, Ma X, Li D, Liu Z, Lu Z.
    Vaccines (Basel); 2021 Apr 15; 9(4):. PubMed ID: 33920779
    [Abstract] [Full Text] [Related]

  • 23. Validation of γ-radiation and ultraviolet as a new inactivators for foot and mouth disease virus in comparison with the traditional methods.
    Mahdy Sel D, Hassanin AI, Gamal El-Din WM, Ibrahim Eel-S, Fakhry HM.
    Vet World; 2015 Sep 15; 8(9):1088-98. PubMed ID: 27047204
    [Abstract] [Full Text] [Related]

  • 24. Correlation between 146S Antigen Content in Foot-and-Mouth Disease Inactivated Vaccines and Immunogenicity Level and Vaccine Potency Alternative Test Methods.
    Li Y, Yang R, Yin F, Zhang H, Zhai G, Sun S, Tian B, Zeng Q.
    Vet Sci; 2024 Apr 08; 11(4):. PubMed ID: 38668435
    [Abstract] [Full Text] [Related]

  • 25. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y, Shao J, Zhao F, Li Y, Lei C, Ma F, Chang H, Zhang Y.
    J Med Virol; 2019 Dec 08; 91(12):2142-2152. PubMed ID: 31347713
    [Abstract] [Full Text] [Related]

  • 26. Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens.
    Kim AY, Kim H, Park SY, Park SH, Kim JS, Park JW, Park JH, Ko YJ.
    Vaccines (Basel); 2021 Mar 12; 9(3):. PubMed ID: 33809252
    [Abstract] [Full Text] [Related]

  • 27. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Chen J, Yu X, Zheng Q, Hou L, Du L, Zhang Y, Qiao X, Hou J, Huang K.
    Vaccine; 2018 Dec 18; 36(52):7929-7935. PubMed ID: 30470640
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison and analysis of the complete nucleotide sequence of foot-and-mouth disease viruses from animals in Korea and other PanAsia strains.
    Oem JK, Lee KN, Cho IS, Kye SJ, Park JH, Joo YS.
    Virus Genes; 2004 Aug 18; 29(1):63-71. PubMed ID: 15215684
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X, Liu R, Tang H, Jin M, Chen H, Qian P.
    Vaccine; 2008 May 23; 26(22):2714-22. PubMed ID: 18436351
    [Abstract] [Full Text] [Related]

  • 37. Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine.
    Horsington J, Zhang Z, Bittner H, Hole K, Singanallur NB, Alexandersen S, Vosloo W.
    Vaccine; 2015 Jan 09; 33(3):422-9. PubMed ID: 25483241
    [Abstract] [Full Text] [Related]

  • 38. Determination of the optimal method for the concentration and purification of 146S particles for foot-and-mouth disease vaccine production.
    Kim H, Kim AY, Kim JS, Lee JM, Kwon M, Bae S, Kim B, Park JW, Park CK, Ko YJ.
    J Virol Methods; 2019 Jul 09; 269():26-29. PubMed ID: 30974178
    [Abstract] [Full Text] [Related]

  • 39. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B, Visser N, Theron J, Rieder E, Maree FF.
    J Gen Virol; 2011 Apr 09; 92(Pt 4):849-59. PubMed ID: 21177923
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.